首页> 外文OA文献 >The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

【2h】

The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

机译：Orlistat，Lonidamine和6-Diazo-5-Oxo-L- Norlleuline的组合诱导静止的能量表型并限制结肠癌细胞中的底物柔性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alejandro Schcolnik‑Cabrera; Alma Chavez‑Blanco; Guadalupe Dominguez‑Gomez; Mandy Juarez; Donna Lai; Sheng Hua; Armando Tovar; Jose Diaz‑Chavez; Alfonso Duenas‑Gonzalez;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer [J] . Cervantes-Madrid Diana, Dominguez-Gomez Guadalupe, Gonzalez-Fierro Aurora, Oncology letters . 2017,第3aPta2期

机译：使用Lonidamine，6-Diazo-5-Oxo-L- Norleuline和Orlistat在结肠癌中同时靶向糖酵解，谷氨酸溶解和脂肪酸合成的可行性和抗肿瘤疗效。
2. Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy [J] . Diana Cervantes-Madrid, Yair Romero, Alfonso Duenas-Gonzalez BioMed research international . 2015,第35期

机译：恢复Lonidamine和6-Diazo-5-Oxo-L- Norleucine用于代谢癌症治疗组合使用
3. Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy [J] . DianaCervantes-Madrid, YairRomero, AlfonsoDue?as-González BioMed research international . 2015,第2期

机译：复活的洛尼达明和6-重氮5-氧代-L-正亮氨酸将联合用于代谢性癌症治疗
4. Combination Effects of Gambogic Acid on Imatinib Mesylate Cytotoxicity in Colon Cancer Cells [C] . El Mon Khaing, THANIKA Saenpunya, PITTAWAS Kerdklai International conference and exhibition on Pharmaceutical Sciences and Technology . 2020

机译：甘伐酸对伊马替尼甲磺酸盐细胞毒性在结肠癌细胞中的组合作用
5. Regulation of proteasome activity and substrate recognition in colon cancer cells [D] . Place, Robert F. 2005

机译：结肠癌细胞中蛋白酶体活性和底物识别的调控
6. Feasibility and antitumor efficacy in vivo of simultaneously targeting glycolysis glutaminolysis and fatty acid synthesis using lonidamine 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer [O] . Diana Cervantes-Madrid, Guadalupe Dominguez-Gomez, Aurora Gonzalez-Fierro, -1

机译：在结肠癌中同时使用lonidamine6-diazo-5-oxo-L-norleucine和orlistat同时靶向糖酵解谷氨酰胺分解和脂肪酸合成的体内可行性和抗肿瘤功效
7. Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines. [O] . Huber, K. R., Mayer, E. P., Mitchell, D. F., 1987

机译：正常和赘生性人类细胞系中6-重氮基-5-氧代-L-正亮氨酸和阿西维星的细胞周期阶段扰动。

The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

著录项

引文网络

相似文献

相关主题

期刊订阅